⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for recurrent nasopharyngeal undifferentiated carcinoma

Every month we try and update this database with for recurrent nasopharyngeal undifferentiated carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Testing the Addition of an Anti-cancer Immune Therapy Drug (Nivolumab) to the Usual Chemotherapy Treatment (Cisplatin or Carboplatin With Gemcitabine) for Recurrent or Metastatic Nasopharyngeal CancerNCT04458909
Metastatic Naso...
Metastatic Naso...
Metastatic Naso...
Metastatic Naso...
Nasopharyngeal ...
Recurrent Nasop...
Recurrent Nasop...
Recurrent Nasop...
Stage IV Nasoph...
Stage IVA Nasop...
Stage IVB Nasop...
Carboplatin
Cisplatin
Gemcitabine
Nivolumab
Questionnaire A...
18 Years - National Cancer Institute (NCI)
Cyclophosphamide for Nasopharyngeal CarcinomaNCT02794077
Recurrent Nasop...
Stage IV Nasoph...
Cyclophosphamid...
15 Years - 80 YearsThe University of Hong Kong
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: